---
title: "Live Birth Rates in Swedish Women with Multiple Sclerosis, 2004–2022"
id: "medrxiv-20-live-birth-rates-among-women-with-multiple-sclerosis-in-sweden-2004-to-2022-a"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-20-live-birth-rates-among-women-with-multiple-sclerosis-in-sweden-2004-to-2022-a"
content_type: "clinical_feed_article"
specialty: "Neurology"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.10.21.26366100v1?rss=1"
published_at: "2026-10-23T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Live Birth Rates in Swedish Women with Multiple Sclerosis, 2004–2022
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-20-live-birth-rates-among-women-with-multiple-sclerosis-in-sweden-2004-to-2022-a
- **Specialty:** [Neurology](https://medichelpline.com/clinical-feed/neurology.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.10.21.26366100v1?rss=1)
- **Published At:** 2026-10-23T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- The investigators linked the Swedish MS Register, National Patient Register and Medical Birth Register with national population counts to compare **live birth rates** between women with **multiple sclerosis (MS)** and all Swedish women from 2004–2022. - The study cohort included 10,452 women with MS contributing 76,989 woman-years and recording 3,577 live births; the authors reported about 1,200 fewer births than expected at national rates. - Observed-to-expected birth ratio for the MS cohort was 0.75 (95% CI 0.72–0.77) overall, indicating roughly 25% fewer births than expected. - Standardised rate ratios were below 1 in every annual comparison; the median standardised rate ratio across years was 0.77. - Period-specific observed-to-expected ratios were 0.73 (95% CI 0.68–0.79) for 2004–2008 and 0.70 (95% CI 0.65–0.75) for 2019–2022; population-by-period interaction p=0.31, suggesting no significant temporal change. - Age- and region-adjusted risk ratios in matched comparisons ranged from 0.75 to 0.86 across periods, with heterogeneity p=0.020 and ratios closest to 1 in 2009–2013. - The study received ethical approval; individual-level register data cannot be publicly shared under Swedish law and no prospective study protocol was registered or published. - Analysis code is available on reasonable request from the corresponding author; funder declared was the Swedish Research Council.
## Clinical Analysis & Structured Key Points
Live Birth Rates Among Women With Multiple Sclerosis in Sweden, 2004 to 2022: A Population-Based Registry Study | medRxiv Skip to main content Live Birth Rates Among Women With Multiple Sclerosis in Sweden, 2004 to 2022: A Population-Based Registry Study View ORCID Profile Timothy P Copeland , View ORCID Profile Kyla A McKay , View ORCID Profile Katharina Fink doi: https://doi.org/10.64898/2026.10.21.26366100 Timothy P Copeland 1 Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Timothy P Copeland For correspondence: copeland.tim{at}gmail.com Kyla A McKay 2 Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden; Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Kyla A McKay Katharina Fink 2 Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden; Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Katharina Fink Abstract Info/History Metrics Supplementary material Data/Code Preview PDF Abstract Background: Women with multiple sclerosis (MS) have fewer children than other women, but whether this narrowed as pregnancy evidence became reassuring and treatment options expanded is uncertain. Objective: To compare live birth trends from 2004 to 2022 between women with MS and all Swedish women. Methods: Linking the Swedish MS, National Patient, and Medical Birth Registers with national statistics, we compared age-standardised live birth rates, counted expected births at national rates, and estimated adjusted annual live-birth risk ratios in a matched comparison sample. Results: Women with MS (n=10,452; 76,989 woman-years) had 3,577 children, about 1,200 (25%) fewer than expected (observed-to-expected ratio 0.75, 95% CI 0.72 to 0.77). Standardised rate ratios were below 1 annually (median 0.77). Observed-to-expected ratios were 0.73 (0.68 to 0.79) in 2004 to 2008 and 0.70 (0.65 to 0.75) in 2019 to 2022 (population-by-period interaction p=0.31). Age- and region-adjusted risk ratios ranged from 0.75 to 0.86 across periods (heterogeneity p=0.020), closest to 1 in 2009 to 2013. Conclusion: Women with MS had about one quarter fewer live births than other Swedish women, and the difference was similar in the first and last periods. Competing Interest Statement TPC reports no competing interests. KAM receives research funding from the Swedish Research Council and ALF Medicine and has received speaker honoraria from Biogen (2022) and Sanofi-Aventis (2023). KF has served on scientific advisory boards for Alexion, Biogen, Janssen, Merck, Novartis, Takeda and Roche, and has received financial research support from Merck and Amicus. Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: The study was approved by the Regional Ethical Review Board in Stockholm (2017/700-31/4), with an amendment approved by the Swedish Ethical Review Authority (2021-02384). The requirement for individual informed consent was waived by the ethical review board because the study used pseudonymised register data. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes Data Availability Individual-level data from the Swedish registers cannot be shared publicly under Swedish law. Researchers may apply for access through the Swedish National Board of Health and Welfare (Socialstyrelsen), Statistics Sweden (SCB), and the Swedish MS Registry, subject to ethical approval. The national birth and population counts are publicly available from the Statistics Sweden statistical database. Analysis code is available from the corresponding author on reasonable request. No study protocol was registered or published. Funder Information Declared Swedish Research Council , 2023-02567 Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. Back to top Previous Next Posted October 23, 2026. Download PDF Supplementary Material Data/Code Email Thank you for your interest in spreading the word about medRxiv. NOTE: Your email address is requested solely to identify you as the sender of this article. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas. You are going to email the following Live Birth Rates Among Women With Multiple Sclerosis in Sweden, 2004 to 2022: A Population-Based Registry Study Message Subject (Your Name) has forwarded a page to you from medRxiv Message Body (Your Name) thought you would like to see this page from the medRxiv website. Your Personal Message CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Share Live Birth Rates Among Women With Multiple Sclerosis in Sweden, 2004 to 2022: A Population-Based Registry Study Timothy P Copeland , Kyla A McKay , Katharina Fink medRxiv 2026.10.21.26366100; doi: https://doi.org/10.64898/2026.10.21.26366100 Share This Article: Copy Citation Tools Live Birth Rates Among Women With Multiple Sclerosis in Sweden, 2004 to 2022: A Population-Based Registry Study Timothy P Copeland , Kyla A McKay , Katharina Fink medRxiv 2026.10.21.26366100; doi: https://doi.org/10.64898/2026.10.21.26366100 Citation Manager Formats BibTeX Bookends EasyBib EndNote (tagged) EndNote 8 (xml) Medlars Mendeley Papers RefWorks Tagged Ref Manager RIS Zotero Tweet Widget Facebook Like Google Plus One Subject Areas All Articles Addiction Medicine (633) Allergy and Immunology (914) Anesthesia (345) Cardiovascular Medicine (4943) Dentistry and Oral Medicine (490) Dermatology (425) Emergency Medicine (671) Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1667) Epidemiology (16161) Forensic Medicine (35) Gastroenterology (1236) Genetic and Genomic Medicine (7209) Geriatric Medicine (747) Health Economics (1091) Health Informatics (5222) Health Policy (1456) Health Systems and Quality Improvement (1812) Hematology (597) HIV/AIDS (1370) Infectious Diseases (except HIV/AIDS) (16426) Intensive Care and Critical Care Medicine (1192) Medical Education (690) Medical Ethics (156) Nephrology (739) Neurology (7497) Nursing (375) Nutrition (1114) Obstetrics and Gynecology (1281) Occupational and Environmental Health (1031) Oncology (3708) Ophthalmology (1079) Orthopedics (401) Otolaryngology (462) Pain Medicine (493) Palliative Medicine (142) Pathology (717) Pediatrics (1844) Pharmacology and Therapeutics (749) Primary Care Research (781) Psychiatry and Clinical Psychology (6065) Public and Global Health (9915) Radiology and Imaging (2499) Rehabilitation Medicine and Physical Therapy (1499) Respiratory Medicine (1263) Rheumatology (655) Sexual and Reproductive Health (794) Sports Medicine (594) Surgery (795) Toxicology (109) Transplantation (315) Urology (303)
## Related Clinical Research

- [Understanding the Complexity of Multiple Sclerosis Diagnosis: Lessons from Christina Applegate](https://medichelpline.com/clinical-feed/stat-news-0-opinion-christina-applegate-puts-a-face-on-one-of-the-most-consequential.md)
- [Patient death reported in Bristol Myers Squibb CAR-T trial for multiple sclerosis](https://medichelpline.com/clinical-feed/stat-news-2-stat-patient-dies-in-bristol-myers-squibb-autoimmune-car-t-trial.md)
- [Hormone Replacement Therapy and Disability Progression in Women with Multiple Sclerosis](https://medichelpline.com/clinical-feed/medrxiv-21-hormone-replacement-therapy-and-disability-progression-in-women-with-multiple.md)
- [Testing frequency explains most SDMT differences between natalizumab and rituximab in Swedish MS r](https://medichelpline.com/clinical-feed/medrxiv-22-more-tests-higher-scores-testing-frequency-and-sdmt-differences-between.md)
- [Ultra-processed foods linked to MRI signs of vascular brain injury in middle-aged adults](https://medichelpline.com/clinical-feed/medical-news-today-0-ultra-processed-foods-may-be-harming-brain-health-in-otherwise-healthy-adults.md)

## Navigation
- [← Back to Neurology Feed](https://medichelpline.com/clinical-feed/neurology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.